ERBB2 and urothelial carcinoma: Her2, one of the Epidermal Growth Factor Receptor protein family members, is an oncogenic receptor tyrosine kinase, and its upregulation was confirmed to be an aggressive behavior-related in many cancers, including urothelial carcinoma (28).